Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma

SuspendedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2026

Conditions
Glioblastoma
Interventions
OTHER

Biorepository

"Tumor collection (\> 1cm3): Intraoperatively~Peripheral blood collection:~* Intraoperatively (60mL +/- 5mL)~* Post-resection (30mL +/- 5mL)~* Post- standard of care treatment (30mL +/- 5 mL)~Bone marrow aspiration:~* Intraoperatively (10mL +/- 5 mL)~* Post-resection (5mL +/- 5 mL)~* Post- standard of care treatment (5mL +/- 5 mL)"

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT04657146 - Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma | Biotech Hunter | Biotech Hunter